Resistant Starch for Inflammatory Bowel Disease
This trial will study whether a specific type of resistant starch can help treat IBD by targeting the gut microbiome.
- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is enrolment for this clinical trial ongoing?
"According to the clinical trials database, this research project is actively seeking participants. Initially published on August 25th 2020, it was last updated on July 19th 2022."
Could I potentially qualify to take part in this scientific experiment?
"This clinical trial seeks 80 volunteers with ileocolitis aged between 5 and 17 years. To be eligible, applicants must demonstrate the capacity to comply with all necessary study procedures (e.g., stool sample collections) throughout its duration as well as provide their informed consent/assent for the collection of such samples."
Is enrollment in this trial open to individuals over the age of 45?
"In order to meet the requirement for participation, individuals must be between 5 and 17 years of age."